This study on fat-1 transgenic mice provided compelling evidence that the IL-17/IL-23 axis is a critical therapeutic target of inflammation in psoriasis and endogenous n-3 PUFAs are potential candidates for the prevention of hyperkeratosis and parakeratosis. Here, IL17A is linked to Hyperkeratosis.